Recent success with the tyrosine kinase inhibitor STI-571--lessons for targeted therapy of cancer. Review uri icon

Overview

publication date

  • March 1, 2001

Research

keywords

  • Antineoplastic Agents
  • Genes, abl
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Piperazines
  • Protein-Tyrosine Kinases
  • Pyrimidines

Identity

Scopus Document Identifier

  • 0035064488

PubMed ID

  • 11575716

Additional Document Info

volume

  • 2

issue

  • 3